ABOUT THIS EVENT
Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company, visited the Nasdaq MarketSite in Times Square.
In honor of the occasion, Mark A. Goldsmith, M.D., Ph.D., President & CEO, rang the Closing Bell.
Please try using other words for your search or explore other sections of the website for relevant information.
Our team is working diligently to resolve the issue. Thank you for your patience and understanding.
February 13, 2020 — 3:45 PM - 4:01 PM ET
Nasdaq MarketSite, 4 Times Square, New York
Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company, visited the Nasdaq MarketSite in Times Square.
In honor of the occasion, Mark A. Goldsmith, M.D., Ph.D., President & CEO, rang the Closing Bell.